Avenue Therapeutics awards 235,000 RSUs to CEO MacLean and interim CFO Jin

AVENUE THERAPEUTICS, INC.

CEO Alexandra MacLean receives 170,000 RSUs; Interim CFO/COO David Jin receives 65,000 RSUs.
RSUs vest in four equal installments on 9/30/24, 12/31/24, 9/20/25, and 9/20/26, subject to continued service.
Settlement deferred until the earlier of Jan 10 after termination of service or a Change in Control.
Awards granted under the company's 2015 Incentive Plan as amended.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.